Vertex Pharmaceuticals is trading at $521.21 (+4.30%) in pre-market on October 19, with a reported Wall Street Zen upgrade a possible contributor. - Wall Street Zen reportedly moved the stock from hold to buy in a Saturday research report. - No major company announcement dated October 19 was found. - Nasdaq futures were higher, while XBI was lower; the available evidence does not establish which factor drove the move.